NewswireToday - /newswire/ -
London, United Kingdom, 2015/01/06 - PathXL announces that it has set up an Advisory Panel to help the company as it continues to grow and expand its worldwide operations. PathXL is delighted at the depth and breadth of the experience brought to the panel by its members - PathXL.com. NYSE: PHG, AEX: PHIA
PathXL today announces the formation of an ‘Advisory Panel’ with active input and contributions from a number of leading names from the worlds of Pathology, Pharmaceuticals, research and clinical delivery.
PathXL is keen to draw on the very substantial experience and knowledge of the panel members as it moves its business planning and execution forward.
The Advisory Panel is chaired by Professor Simon Best, a member of PathXL’s Board with wide experience as a Founder, CEO and Chairman or Board Member of Companies in all major sectors of the Life Science Industry, and a Chairman or Trustee of major Industry Bodies and Public Sector Institutions in the UK, USA, Europe, Asia and Latin America.
The eight distinguished members of the panel each have a powerful ability to assist the company. Combined, they bring deep sector expertise in Academic Research, Life Sciences, Pathology, Digital Pathology, Veterinary Pathology, the Bio-Pharma industry generally, Clinical Research Organisations, Digital Imaging and Bio-banking.
Des Speed, PathXL CEO said,
"We are delighted to have such a combination of expertise on our Advisory Panel. Their contribution has already proved excellent and we look forward to hearing their thoughts and challenges to our plans, both in product and market terms. Having such an experienced group contributing to our strategy is immensely helpful. We are deeply grateful to them for their time and interest."
PathXL (pathxl.com) is a global pioneer in the use of web-based solutions for digital pathology, and provides innovative software for use in drug discovery research, clinical sectors, biomarker analysis and education. Their product for the automated identification and annotation of tumour tissue, TissueMark, was awarded the Frost and Sullivan 2014 European New Product Innovation Award for Automated Image Analysis for Digital Pathology. PathXL has just launched Xplore a new application for image and data management, aiming to facilitate studies for Researchers worldwide.